Literature DB >> 7155962

Effects of dopamine and dobutamine on the myocardial and systemic circulation during and following cardiopulmonary bypass in dogs.

H B Ward, S Einzig, R W Bianco, T Wang, J E Foker.   

Abstract

The effect of dopamine (Dp) and dobutamine (Db) on myocardial and systemic blood flow (BF) distribution was compared in dogs being weaned from cardiopulmonary bypass (CPB) after 20 min of normothermic global myocardial ischemia. Drug infusions (10 mcg/kg/min) were begun and BF was measured (radiolabeled microspheres) prior to weaning and 60 min off CPB. On CPB: Pump flows, by design, were similar (100 ml/kg/min) in Dp, Db, and saline control (NS) dogs. Dp and Db significantly (p less than 0.05) increased myocardial BF. Dp did not alter renal, visceral, and skeletal muscle BF and only increased BF to the cervical spinal cord and medulla. Db, however, significantly reduced renal (-49%), splenci (-58%), pancreatic (-27%), and colonic (-47%) BF but increased perfusion in essentially all of the central nervous system. Off CPB: Cardiac output during Dp and Db infusions was significantly greater than NS dogs (107 +/- 7 vs 152 +/- 12 vs 82 +/- 10 ml/kg/min resp.); the greater increase for Db resulting from a larger stroke volume. Dp and Db significantly increased myocardial BF. Dp increased splenic (+77%), gastric (+139%), and gallbladder (+125%) BF but had no effect on renal, hepatic, skeletal muscle, and intestinal BF. Db infusion maintained renal BF similar to NS and elevated BF to most visceral organs. The results of this study show that the myocardium responded to inotropic stimulation despite the previous ischemic insult but the BF changes varied among regional vascular beds with Dp and Db infusions during and following CPB. Of the 2 drugs, Db showed the greater inotropic response off CPB, a similar increase in myocardial perfusion and greater visceral organ bloodflow.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7155962     DOI: 10.1007/BF02240462

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  23 in total

1.  Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs.

Authors:  S F Vatner; R J McRitchie; E Braunwald
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

2.  Hemodynamic effects of dobutamine and epinephrine in patients during coronary surgery.

Authors:  S Piepenbrock; W Reichelt; G Hempelmann; A Brackertz; D Dragojevic; R Hetzer
Journal:  Thorac Cardiovasc Surg       Date:  1979-12       Impact factor: 1.827

3.  Dobutamine for inotropic support during emergence from cardiopulmonary bypass.

Authors:  J H Tinker; S Tarhan; R D White; J R Pluth; D A Barnhorst
Journal:  Anesthesiology       Date:  1976-04       Impact factor: 7.892

4.  Hemodynamic effect of dobutamine in patients with severe heart failure.

Authors:  N Akhtar; E Mikulic; J N Cohn; M H Chaudhry
Journal:  Am J Cardiol       Date:  1975-08       Impact factor: 2.778

5.  Hemodynamic effects of dobutamine in patients following open heart surgery.

Authors:  T Sakamoto; T Yamada
Journal:  Circulation       Date:  1977-03       Impact factor: 29.690

6.  Effects of catecholamines, exercise, and nitroglycerin on the normal and ischemic myocardium in conscious dogs.

Authors:  S F Vatner; R J McRitchie; P R Maroko; T A Patrick; E Braunwald
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

7.  Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure.

Authors:  C V Leier; P T Heban; P Huss; C A Bush; R P Lewis
Journal:  Circulation       Date:  1978-09       Impact factor: 29.690

8.  Adenosine metabolism and myocardial preservation. Consequences of adenosine catabolism on myocardial high-energy compounds and tissue blood flow.

Authors:  J E Foker; S Einzig; T Wang
Journal:  J Thorac Cardiovasc Surg       Date:  1980-10       Impact factor: 5.209

9.  Combined use of phenoxybenzamine and dopamine for low cardiac output syndrome in children at withdrawal from cardiopulmonary bypass.

Authors:  M Kawamura; O Minamikawa; H Yokochi; S Maki; T Yasuda; Y Mizukawa
Journal:  Br Heart J       Date:  1980-04

10.  Dopamine and saralasin antagonism of renal vasoconstriction and oliguria caused by amphotericin B in dogs.

Authors:  N E Reiner; W L Thompson
Journal:  J Infect Dis       Date:  1979-10       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.